IndraLab
Statements
reach
"According to our findings that VCL directly interacts with SCN5A invivo and invitro and that VCL and SCN5A were colocalized at the ID in the human heart, this functional effect may result from the direct association between VCL and SCN5A.17 However, the fact that VCL-D841H did not affect the interaction between VCL and SCN5A suggested that the molecular mechanism for this functional interaction remains to be addressed."
sparser
"To explore the relationship between VCL and SCN5A, we used co-immunoprecipitation experiments to examine if VCL physically interacts with SCN5A. In mouse heart tissues, immunoblot analysis of immunoprecipitated VCL detected the presence of SCN5A, and we also found VCL present following a reciprocal immunoprecipitate using the antibody against SCN5A; due to the negative expression of SCN5A, mouse liver tissue was used as a control ( xref )."
sparser
"Co-immunoprecipitation also showed that VCL-M94I didn’t affect the physical interaction between VCL and SCN5A. These results suggest the observed functional effect of mutant VCL-M94I on SCN5A does not involve expression and distribution of VCL or SCN5A. The precise mechanism for decreased I Na observed ( xref and xref ) is unclear."
sparser
"Through biophysical investigation, we have now linked a VCL variant M94I to the loss-of-function of cardiac sodium channel in both HEK293 cells and iPSC-CMs, showing a previously unknown functional interaction between VCL and SCN5A. In the myocardial section from the VCL-M94I carrier, we confirmed the co-localization of VCL and SCN5A at ID, but didn’t find significant difference in distribution of both VCL and SCN5A compared to control."